๐ฐEarnings Season will start from next weekend๐ฐ
Here are some of the key metrics I will be monitoring for some of my portfolio and watchlist companies ๐
Here are some of the key metrics I will be monitoring for some of my portfolio and watchlist companies ๐
Since, each tweet has limited space, I will be using the below emojis to denote expectations from Q2 Results
๐ Excellent
๐ Above Expectations
๐ On Par with Expectations
๐ Below Expectations but still Okay
โน๏ธ Bad Results
๐ Excellent
๐ Above Expectations
๐ On Par with Expectations
๐ Below Expectations but still Okay
โน๏ธ Bad Results
Now that you're familiar with above very complicated 5 point metric scale, its time to list our expectations and key monitorables for each company.
Key Monitorables
1. The increase in their FDF Revenue since new capacities came online in Q2FY22
2. Incremental Revenue from Laurus Bio
3. Update on CAPEX
4. Do margins stay above 30%?
5. Quantum of Impact of Shipping Costs
6. Updates on Laurus Synthesis and CDMO business
1. The increase in their FDF Revenue since new capacities came online in Q2FY22
2. Incremental Revenue from Laurus Bio
3. Update on CAPEX
4. Do margins stay above 30%?
5. Quantum of Impact of Shipping Costs
6. Updates on Laurus Synthesis and CDMO business
Key Monitorables
1. Custom duty on import of solar modules expired in Aug & new duty doesn't kick in until Apr'22, Impact of this on Sales should show if they are severely impacted
2. Solar Glass prices were stable throughout Qtr so margin should be stable (>35%)
3. Export Nos
1. Custom duty on import of solar modules expired in Aug & new duty doesn't kick in until Apr'22, Impact of this on Sales should show if they are severely impacted
2. Solar Glass prices were stable throughout Qtr so margin should be stable (>35%)
3. Export Nos
Key Monitorables
1. Updates on Capex Progress
2. Incremental share of Spec Chem segment in results
3. Any changes in margin, above 17% is great, if it enters 20%+, that may re-rate the company further (high probability since prices for finished goods were high throughout the Q)
1. Updates on Capex Progress
2. Incremental share of Spec Chem segment in results
3. Any changes in margin, above 17% is great, if it enters 20%+, that may re-rate the company further (high probability since prices for finished goods were high throughout the Q)
Key Monitorables
1. IEX publishes monthly & weekly data, so I have a pretty good idea of what to expect from results, they should be above 95cr
2. Will be looking for updates on Green Energy & Renewable Energy Certificates
3. Updates in Indian Gas Exchange
4. Dividend Details
1. IEX publishes monthly & weekly data, so I have a pretty good idea of what to expect from results, they should be above 95cr
2. Will be looking for updates on Green Energy & Renewable Energy Certificates
3. Updates in Indian Gas Exchange
4. Dividend Details
Key Monitorables
1. Margins, do they bounce back or remain depressed?
2. Any further impact of ESOPs?
3. Resolutions of customer debts in Turkey
4. Any impact of Lira on Revenues and its quantum
5. Updates from Stonehaven (if any)
6. Progress of products in regulatory markets
1. Margins, do they bounce back or remain depressed?
2. Any further impact of ESOPs?
3. Resolutions of customer debts in Turkey
4. Any impact of Lira on Revenues and its quantum
5. Updates from Stonehaven (if any)
6. Progress of products in regulatory markets
Key Monitorables
1. Impact of shipping costs on margins
2. Updates on progress of CAPEX
3. Margins, if they bounce back to 25%
4. Updates on EV client and expected date of sales
1. Impact of shipping costs on margins
2. Updates on progress of CAPEX
3. Margins, if they bounce back to 25%
4. Updates on EV client and expected date of sales
Key Monitorables
1. Updates on operations of NY facility they acquired from Endo
2. Whether expenses come down to less than 600cr
3. Any further price erosion (high probability)
4. Updates on Stelis and Sputnik V vaccine
1. Updates on operations of NY facility they acquired from Endo
2. Whether expenses come down to less than 600cr
3. Any further price erosion (high probability)
4. Updates on Stelis and Sputnik V vaccine
Key Monitorables
1. Op. Margin, if it dips below 30%
2. The Phenol Spreads did decrease this Quarter, so my expectations are around 750cr from Phenolics and 1300cr overall
3. Warning - Any big miss in revenue estimate for Qtr may cause the stock to correct
1. Op. Margin, if it dips below 30%
2. The Phenol Spreads did decrease this Quarter, so my expectations are around 750cr from Phenolics and 1300cr overall
3. Warning - Any big miss in revenue estimate for Qtr may cause the stock to correct
Key Monitorables
1. Divis has a very high chance of doing 2000cr+ in revenue this quarter
2. Their margins are constantly on the rise, any increase beyond 43% Op. Margin in Qtr may re-rate the stock even further
3. High probability of EPS > 21 for Qtr
1. Divis has a very high chance of doing 2000cr+ in revenue this quarter
2. Their margins are constantly on the rise, any increase beyond 43% Op. Margin in Qtr may re-rate the stock even further
3. High probability of EPS > 21 for Qtr
Key Monitorables
1. Monitor only Renewables part of Tata Power to gauge an estimate of renewables business in India
2. A growth in Renewables segment means good pickup for other renewables business esp. Borosil Renew (BR)
3. This serves as an early indicator of BR results
1. Monitor only Renewables part of Tata Power to gauge an estimate of renewables business in India
2. A growth in Renewables segment means good pickup for other renewables business esp. Borosil Renew (BR)
3. This serves as an early indicator of BR results
These are just some of the key companies I will be keenly watching results for.
Should you care about bad Quarterly Results?
Depends, if you're a long term (LT) investor or a trader.
For LT, its normal for business earnings to undergo hiccups Quarterly.
We as investors need to decide if the reasons for those hiccups are temporary or permanent.
Depends, if you're a long term (LT) investor or a trader.
For LT, its normal for business earnings to undergo hiccups Quarterly.
We as investors need to decide if the reasons for those hiccups are temporary or permanent.
Loading suggestions...